| Median (range) |  |  |
---|---|---|---|
Age |  | 73 (65–96) |  |
Age-adjusted CCI |  | 4 (2–9) |  |
 |  | n | % |
Gender | Male | 48 | 76.2 |
 | Female | 15 | 23.8 |
Smoking | Non-smoker | 17 | 27.0 |
 | Smoker | 42 | 66.7 |
 | Missing | 4 | 6.3 |
ECOG | ECOG 0 | 31 | 49.2 |
 | ECOG 1 | 27 | 42.9 |
 | ECOG 2 | 5 | 7.9 |
Localization | Nasopharynx | 3 | 4.8 |
 | Oropharynx | 26 | 41.3 |
 | Hypopharynx | 12 | 19.0 |
 | Oral cavity | 7 | 11.1 |
 | Larynx | 13 | 20.6 |
 | Multi-level | 1 | 1.6 |
 | Parotid gland | 1 | 1.6 |
UICC | I | 6 | 9.5 |
 | II | 2 | 3.2 |
 | III | 5 | 7.9 |
 | IV | 50 | 79.4 |
cT | cT1 | 7 | 11.1 |
 | cT2 | 10 | 15.9 |
 | cT3 | 16 | 25.4 |
 | cT4 | 30 | 47.6 |
cN | cN0 | 16 | 25.4 |
 | cN1 | 3 | 4.8 |
 | cN2a | 1 | 1.6 |
 | cN2b | 25 | 39.7 |
 | cN2c | 15 | 23.8 |
 | cN3 | 3 | 4.8 |
cM | cM0 | 63 | 100.0 |
 | cM1 | 0 | 0.0 |
Grading | G1 | 2 | 3.2 |
 | G2 | 43 | 68.3 |
 | G3 | 18 | 28.6 |
HPV | HPV-negative | 25 | 39.7 |
 | HPV-positive | 13 | 20.6 |
 | Missing | 25 | 39.7 |
 |  | Median (range) |  |
Dose (EQD2) |  | 69.4 Gy (40.0–70.0 Gy) |  |
 |  | n | % |
Radiotherapy completed | Not completed | 11 | 17.5 |
 | Completed | 52 | 82.5 |
Chemotherapy | No chemotherapy | 19 | 30.2 |
 | Chemotherapy | 44 | 69.8 |